Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: IBM, Good Start Genetics among Recent Bioinformatics Patent Winners

Premium

Title: Minimization of surprisal data through application of hierarchy of reference genomes

US Patent Number: 8,855,938

Assignee: International Business Machines

Inventors: Robert Friedlander, James Kraemer


Title: Computational method and apparatus for predicting polypeptide aggregation or solubility

US Patent Number: 8,849,578

Assignee: Cambridge University Technical Services

Inventor: Christopher Dobson, Fabrizio Chiti, Jesus Zurdo


Title: Phylogenetic analysis of mass spectrometry or gene array data for the diagnosis of physiological conditions

US Patent Number: 8,849,576

Inventor: Hakima Amri, Mones Abu-asab, Mohamed Chaouchi


Title: Computational method and apparatus for predicting polypeptide aggregation or solubility

US Patent Number: 8,847,799

Assignee: Good Start Genetics

Inventor: Caleb Kennedy, Niru Chennagiri


Title: Computer systems and methods for associating genes with traits using cross species data

US Patent Number: 8,843,356

Assignee: Merck Sharp & Dohme Corp.

Inventor: Eric Schadt, John Lamb


The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.